These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6306544)

  • 21. Prophylaxis of Hemophilus influenzae type b disease.
    Band JD; Fraser DW; Hightower AW; Broome CV
    JAMA; 1984 Dec; 252(23):3249-50. PubMed ID: 6334756
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of vaccines and antibiotic prophylaxis in contacts and cases of Haemophilus influenzae type b (Hib) disease.
    Cartwright KA; Begg NT; Rudd PT
    Commun Dis Rep CDR Rev; 1994 Feb; 4(2):R16-7. PubMed ID: 7511459
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharyngeal carriage and antimicrobial resistance of Haemophilus influenzae in non-type-b-vaccinated healthy children attending day care centers in Turkey.
    Torun MM; Namal N; Demirci M; Bahar H; Kocazeybek B
    Chemotherapy; 2007; 53(2):114-7. PubMed ID: 17308377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemophilus influenzae type b in a day care center: relationship of nasopharyngeal carriage to development of anticapsular antibody.
    Granoff DM; Gilsdorf J; Gessert CE; Lowe L
    Pediatrics; 1980 Jan; 65(1):65-8. PubMed ID: 6965531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continued shortage of Haemophilus influenzae Type b (Hib) conjugate vaccines and potential implications for Hib surveillance--United States, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1252-5. PubMed ID: 19023262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Invasive infections caused by haemophilus influenzae serotypes in twelve Canadian IMPACT centers, 1996-2001.
    McConnell A; Tan B; Scheifele D; Halperin S; Vaudry W; Law B; Embree J;
    Pediatr Infect Dis J; 2007 Nov; 26(11):1025-31. PubMed ID: 17984810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: recommendations for immunization with recently and previously licensed vaccines.
    Pediatrics; 1993 Sep; 92(3):480-8. PubMed ID: 8361814
    [No Abstract]   [Full Text] [Related]  

  • 28. Rifampin prophylaxis against H. flu type b spread - is it valid?
    Daum RS; Glode MP
    Hosp Pract (Off Ed); 1982 Nov; 17(11):124A-C, 124K-L, 124N-P. PubMed ID: 6813223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Point: recommendations for rifampin prophylaxis of Haemophilus infections by the Committee on Infectious Diseases of the American Academy of Pediatrics.
    Fulginiti VA
    Pediatr Infect Dis; 1982; 1(6):377-8. PubMed ID: 7163025
    [No Abstract]   [Full Text] [Related]  

  • 30. Diversity and sharing of Haemophilus influenzae strains colonizing healthy children attending day-care centers.
    Farjo RS; Foxman B; Patel MJ; Zhang L; Pettigrew MM; McCoy SI; Marrs CF; Gilsdorf JR
    Pediatr Infect Dis J; 2004 Jan; 23(1):41-6. PubMed ID: 14743045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidelines for dealing with the guidelines: rifampin prophylaxis for day care contacts of patients with serious Haemophilus influenzae type b infections.
    Daum RS; Gilsdorf J; Granoff D; Murphy T; Osterholm M
    J Pediatr; 1984 Nov; 105(5):761-3. PubMed ID: 6334148
    [No Abstract]   [Full Text] [Related]  

  • 32. Rifampin for eradicating carriage of multiply resistant Haemophilus influenzae b.
    Campos J; Garcia-Tornel S; Roca J; Iriondo M
    Pediatr Infect Dis J; 1987 Aug; 6(8):719-21. PubMed ID: 3499591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary rates of Haemophilus influenzae type b disease among day care contacts.
    Marks MI; Dorchester WL
    J Pediatr; 1987 Aug; 111(2):305-6. PubMed ID: 3497253
    [No Abstract]   [Full Text] [Related]  

  • 34. Secondary Haemophilus influenzae type b in day-care facilities. Risk factors and prevention.
    Fleming DW; Leibenhaut MH; Albanes D; Cochi SL; Hightower AW; Makintubee S; Helgerson SD; Broome CV
    JAMA; 1985 Jul; 254(4):509-14. PubMed ID: 3874293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunization against Haemophilus influenzae type b in Sweden--a study of the introduction process.
    Garpenholt O; Fredlund H; Timpka T
    Scand J Public Health; 2001 Dec; 29(4):271-8. PubMed ID: 11775783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of Haemophilus influenzae type b invasive disease in New York State, 1987 to 1991: the role of vaccination requirements for day-care attendance.
    Schulte EE; Birkhead GS; Kondracki SF; Morse DL
    Pediatrics; 1994 Dec; 94(6 Pt 2):1014-6. PubMed ID: 7971041
    [No Abstract]   [Full Text] [Related]  

  • 37. Recent advances in communicable disease prevention: hepatitis B, pneumococcus, and H influenzae type b.
    Colburn PA; Ross MB
    Hosp Formul; 1988 May; 23(5):448-50, 453-7. PubMed ID: 10314280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of immunization on Haemophilus influenzae type b disease.
    Madore DV
    Infect Agents Dis; 1996 Jan; 5(1):8-20. PubMed ID: 8789595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of H. influenzae in a day-care center.
    Akçakaya N; Torun MM; Söylemez Y; Sevme R; Cokuğraş H; Ergin S; Pinçe O; Eşkazan G
    Turk J Pediatr; 1996; 38(3):289-93. PubMed ID: 8827896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rifampin alone and in combination with trimethoprim in chemoprophylaxis for infections due to Haemophilus influenzae type b.
    Glode MP; Daum RS; Halsey NA; Johansen TL; Goldmann DA; Ambrosino D; Boies E; Granoff DM
    Rev Infect Dis; 1983; 5 Suppl 3():S549-55. PubMed ID: 6605565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.